Search Results - "Muir, K. T."

Refine Results
  1. 1

    Remifentanil by bolus injection: a safety, pharmacokinetic, pharmacodynamic, and age effect investigation in human volunteers by Egan, T.D., Kern, S.E., Muir, K.T., White, J

    Published in British journal of anaesthesia : BJA (01-03-2004)
    “…Although remifentanil's short-acting pharmacokinetic profile makes it well suited for procedures during which a brief period of intense analgesia is required,…”
    Get full text
    Journal Article
  2. 2

    Measured context-sensitive half-times of remifentanil and alfentanil by KAPILA, A, GLASS, P. S. A, JACOBS, J. R, MUIR, K. T, HERMANN, D. J, SHIRAISHI, M, HOWELL, S, SMITH, R. L

    Published in Anesthesiology (Philadelphia) (01-11-1995)
    “…The context-sensitive half-time, rather than the terminal elimination half-life, has been proposed as a more clinically relevant measure of decreasing drug…”
    Get full text
    Journal Article
  3. 3

    Remifentanil versus alfentanil : Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers by EGAN, T. D, MINTO, C. F, HERMANN, D. J, BARR, J, MUIR, K. T, SHAFER, S. L

    Published in Anesthesiology (Philadelphia) (01-04-1996)
    “…Remifentanil is an esterase-metabolized opioid with a rapid clearance. The aim of this study was to contrast the pharmacokinetics and pharmacodynamics of…”
    Get full text
    Journal Article
  4. 4

    The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers by EGAN, T. D, LEMMENS, H. J. M, FISET, P, HERMANN, D. J, MUIR, K. T, STANSKI, D. R, SHAFER, S. L

    Published in Anesthesiology (Philadelphia) (01-11-1993)
    “…Remifentanil (GI87084B) is a new short-acting opioid with a unique ester structure. Metabolism of remifentanil by ester hydrolysis results in very rapid…”
    Get full text
    Conference Proceeding Journal Article
  5. 5

    Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery by WESTMORELAND, C. L, HOKE, J. F, SEBEL, P. S, HUG, C. C, MUIR, K. T

    Published in Anesthesiology (Philadelphia) (01-11-1993)
    “…Remifentanil is a highly potent opioid with a rapid onset and a short duration of action due to its rapid hydrolysis by esterases in blood and tissues. The…”
    Get full text
    Journal Article
  6. 6

    Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers by HOKE, J. F, SHLUGMAN, D, GLASS, P. S. A, DERSHWITZ, M, MICHAŁOWSKI, P, MALTHOUSE-DUFORE, S, CONNORS, P. M, MARTEL, D, ROSOW, C. E, MUIR, K. T, RUBIN, N

    Published in Anesthesiology (Philadelphia) (01-09-1997)
    “…Remifentanil is an opioid analgesic for use in anesthesia. An ester linkage renders it susceptible to rapid metabolism by blood and tissue esterases. Thus it…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease by DERSHWITZ, M, HOKE, J. F, ROSOW, C. E, MICHAŁOWSKI, P, CONNORS, P. M, MUIR, K. T, DIENSTAG, J. L

    Published in Anesthesiology (Philadelphia) (01-04-1996)
    “…Remifentanil, a new mu-opioid agonist with an extremely short duration of action, is metabolized by circulating and tissue esterases; therefore, its clearance…”
    Get full text
    Journal Article
  8. 8

    Metabolism of remifentanil during liver transplantation by Navapurkar, V U, Archer, S, Gupta, S K, Muir, K T, Frazer, N, Park, G R

    Published in British journal of anaesthesia : BJA (01-12-1998)
    “…We have investigated the pharmacokinetics of remifentanil and its less potent metabolite, GR90291, in six adult patients undergoing orthotopic liver…”
    Get full text
    Journal Article
  9. 9

    The comparative pharmacodynamics of Remifentanil and its metabolite, GR90291, in a rat electroencephalographic model by COX, E. H, LANGEMEIJER, M. W. E, GUBBENS-STIBBE, J. M, MUIR, K. T, DANHOF, M

    Published in Anesthesiology (Philadelphia) (01-02-1999)
    “…The purpose of this study was to investigate the in vivo pharmacodynamics and the pharmacodynamic interactions of remifentanil and its major metabolite,…”
    Get full text
    Journal Article
  10. 10

    Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamics by Hermann, David J., Egan, Talmage D., Muir, Keith T.

    Published in Clinical pharmacology and therapeutics (01-05-1999)
    “…Introduction Remifentanil is a new, short‐acting, rapidly metabolized opioid. Because remifentanil is metabolized in blood and tissues by nonspecific…”
    Get full text
    Journal Article
  11. 11

    Pharmacokinetics of Remifentanil in Anesthetized Pediatric Patients Undergoing Elective Surgery or Diagnostic Procedures by Ross, Allison Kinder, Davis, Peter J., Dear, Guy deL, Ginsberg, Brian, McGowan, Francis X., Stiller, Richard D., Henson, Lynn Graham, Huffman, Cameron, Muir, Keith T.

    Published in Anesthesia and analgesia (01-12-2001)
    “…Remifentanil hydrochloride is an ultra-short-acting opioid that undergoes rapid metabolism by tissue and plasma esterases. We aimed to characterize the…”
    Get full text
    Journal Article
  12. 12

    Evaluating a possible pharmacokinetic interaction between remifentanil and esmolol in the rat by Haidar, S H, Moreton, J E, Liang, Z, Hoke, J F, Muir, K T, Eddington, N D

    Published in Journal of pharmaceutical sciences (01-11-1997)
    “…Remifentanil (Ultiva) is a novel, ultra-short-acting opioid which has recently been approved for use as an analgesic during induction and maintenance of…”
    Get more information
    Journal Article
  13. 13

    Remifentanil pharmacokinetics in obese versus lean patients by Egan, T D, Huizinga, B, Gupta, S K, Jaarsma, R L, Sperry, R J, Yee, J B, Muir, K T

    Published in Anesthesiology (Philadelphia) (01-09-1998)
    “…Remifentanil is a short-acting opioid whose pharmacokinetics have been characterized in detail. However, the impact of obesity on remifentanil pharmacokinetics…”
    Get full text
    Journal Article
  14. 14

    The pharmacokinetics and electroencephalogram response of remifentanil alone and in combination with esmolol in the rat by HAIDAR, S. H, MORETON, J. E, LIANG, Z, HOKE, J. F, MUIR, K. T, EDDINGTON, N. D

    Published in Pharmaceutical research (01-12-1997)
    “…The goal of this study was to determine if the co-administration of esmolol (ES), a short acting cardioselective beta-blocker, significantly alters the…”
    Get full text
    Journal Article
  15. 15

    Remifentanil and Pulmonary Extraction During and After Cardiac Anesthesia by Duthie, David J. R, Stevens, Jan J. W. M, Doyle, Anthony R, Baddoo, Henry H. K, Gupta, Samir K, Muir, Keith T, Kirkham, Andrew J. T

    Published in Anesthesia and analgesia (01-04-1997)
    “…We measured the apparent blood clearance and pulmonary extraction ratio of remifentanil in 10 adult patients undergoing elective myocardial revascularization…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs by Hoke, J F, Cunningham, F, James, M K, Muir, K T, Hoffman, W E

    “…Remifentanil is an esterase-metabolized opioid developed for use in anesthesia. The principal metabolite of remifentanil, GR90291, is considered to be less…”
    Get more information
    Journal Article
  18. 18

    Histamine Concentrations and Hemodynamic Responses After Remifentamil by Sebel, Peter S., Hoke, John F., Westmoreland, Cheryl, Hug, Carl C., Muir, Keith T., Szlam, Fania

    Published in Anesthesia and analgesia (01-05-1995)
    “…Remifentanil is a new potent opioid analgesic that undergoes rapid esterase metabolism.The purpose of this study was to investigate hemodynamic responses to…”
    Get full text
    Journal Article
  19. 19
  20. 20